# EDGAR Filing Document

**Accession Number:** 0001585364
**File Stem:** 0001193125-23-030278
**Filing Date:** 2023-2
**Character Count:** 5617
**Document Hash:** 1869bc49759eca7911705d14b94150a1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-030278.hdr.sgml**: 20230209

**ACCESSION NUMBER**: 0001193125-23-030278

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230207

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230209

**DATE AS OF CHANGE**: 20230209

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PERRIGO Co plc
- **CENTRAL INDEX KEY:** 0001585364
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36353
- **FILM NUMBER:** 23607148

**BUSINESS ADDRESS:**
- **STREET 1:** THE SHARP BUILDING
- **STREET 2:** HOGAN PLACE
- **CITY:** DUBLIN 2
- **STATE:** L2
- **ZIP:** D02 TY74
- **BUSINESS PHONE:** 269-673-8451

**MAIL ADDRESS:**
- **STREET 1:** 515 EASTERN AVENUE
- **CITY:** ALLEGAN
- **STATE:** MI
- **ZIP:** 49010

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PERRIGO Co Ltd
- **DATE OF NAME CHANGE:** 20130828

?xml version="1.0" encoding="utf-8" ? 8-K

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, D.C. 20549

------

### FORM 8-K

------

#### CURRENT REPORT

#### Pursuant to Section 13 OR 15(d)

#### of The Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported):

#### February 7, 2023

------

## Perrigo Company plc

#### (Exact name of registrant as specified in its charter)

------

---

| | | |
|:---|:---|:---|
|  | **Commission file number 001-36353** |  |
| **Ireland** |  | **Not Applicable** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** |  | **(I.R.S. Employer**<br> **Identification No.)** |

---

#### The Sharp Building, Hogan Place, Dublin 2, Ireland D02 TY74

#### +353 1 7094000

#### (Address, including zip code, and telephone number, including

#### area code, of registrant's principal executive offices)

#### Not Applicable

#### (Former name or former address, if changed since last report)

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities Registered pursuant to section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br> **Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| Ordinary shares, €0.001 par value | PRGO | New York Stock Exchange |
| 3.900% Notes due 2024 | PRGO24 | New York Stock Exchange |
| 4.375% Notes due 2026 | PRGO26 | New York Stock Exchange |
| 4.400% Notes due 2030 | PRGO30 | New York Stock Exchange |
| 5.300% Notes due 2043 | PRGO43 | New York Stock Exchange |
| 4.900% Notes due 2044 | PRGO44 | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.02.** | **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**  |

---

On February 7, 2023, Theodore R. Samuels, an independent member of the Perrigo Company plc Board of Directors, advised Perrigo's Nominating & Governance Committee that he will not stand for re-election to our Board of Directors at the Company's annual general meeting of shareholders in 2023 and intends to retire from our Board at that time. Mr. Samuels, 68, has been a member of the Board since 2017 and currently serves on our Audit Committee and Nominating and Governance Committee. Mr. Samuels' decision to retire is not the result of any disagreement with the Company, and he will continue in his role as director until the 2023 annual general meeting.

Murray Kessler, Perrigo's President and CEO, said: "On behalf of the entire Board and management team, I want to thank Ted for his dedicated and effective service to the Company since 2017. He has been an outstanding director and we are thankful for his contributions over the years as we have transformed Perrigo into a consumer self-care company."

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | (Registrant) | (Registrant) |
|  | PERRIGO COMPANY PLC | PERRIGO COMPANY PLC |
|  | By: | /s/ Eduardo Bezerra |
| Dated: February 9, 2023 |  | Eduardo Bezerra |
|  |  | Chief Financial Officer |

---